Influenza Therapeutic Trial: A Pilot Randomized Controlled Trial for Feasibility of Enrolling Subjects for Influenza Therapeutic Trials and Administering Influenza Antivirals in the Emergency Department to High Risk Subjects
Phase of Trial: Phase IV
Latest Information Update: 29 Sep 2017
At a glance
- Drugs Oseltamivir (Primary) ; Peramivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 15 Sep 2017 Status changed from recruiting to completed.
- 17 Oct 2016 Planned number of patients changed from 100 to 225.
- 17 Oct 2016 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.